StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$26.71−1.02 (-3.70%)

Close on Nov 20, 2026Market cap $4.64BP/E –Yield –

Cogent Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cogent Biosciences's revenue for the twelve months ending Dec 31, 2020 was $7.87M, down 65.0% year over year. For fiscal 2020 it was $7.87M, down 65.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$7.87M-65.0%
FY2019Dec 31, 2019$22.50M+131.1%
FY2018Dec 31, 2018$9.73M+16.4%
FY2017Dec 31, 2017$8.36M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$312.00K-69.4%
Q2 FY2020Jun 30, 2020$528.00K-83.2%
Q1 FY2020Mar 31, 2020$7.03M+130.3%
Q4 FY2019Dec 31, 2019$15.29M+301.8%
Q3 FY2019Sep 30, 2019$1.02M-50.1%
Q2 FY2019Jun 30, 2019$3.14M+88.4%
Q1 FY2019Mar 31, 2019$3.05M+37.5%
Q4 FY2018Dec 31, 2018$3.81M+79.2%
Q3 FY2018Sep 30, 2018$2.04M-12.4%
Q2 FY2018Jun 30, 2018$1.67M-19.9%
Q1 FY2018Mar 31, 2018$2.22M+21.5%
Q4 FY2017Dec 31, 2017$2.12M–
Q3 FY2017Sep 30, 2017$2.33M–
Q2 FY2017Jun 30, 2017$2.08M–
Q1 FY2017Mar 31, 2017$1.83M–

More Cogent Biosciences figures

See a number that looks wrong?